ArticleInternational journal of cardiology. Cardiovascular risk and prevention2025
Aortic dissection mortality in the United States, 1968-2023: Trends, disparities, and deep learning forecasts.
Article in International journal of cardiology. Cardiovascular risk and prevention, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Metachronous contralateral pheochromocytoma detected 62 years after initial surgery.JCEM case reports · 2026Article
- Mortality trends and disparities associated with aortic aneurysm and aortic dissection in the United States from 1999 to 2023: a CDC WONDER database analysis.BMC cardiovascular disorders · 2026Article
- Nationwide patterns of cardiac-related mortality in amyloidosis cases: an epidemiologic study.BMC cardiovascular disorders · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The population-level burden and inequities of aortic dissection (AD) mortality in the United States remain incompletely defined, and contemporary, data-driven forecasts are scarce. Methods: Using the CDC WONDER Death database (1968-2023), AD deaths were identified by ICD codes (ICD-8/9: 441.0; ICD-10: I71.0). Age-adjusted mortality rates (AAMRs) per 100,000 were stratified by sex, race, age, and Census region. Temporal trends were assessed using Joinpoint regression to estimate annual percent change (APC) and average APC (AAPC). Forecasts through 2033 employed a Bi-GRU model. Results: We analyzed 175,930 AD-related deaths. Overall, the national AAMR declined by 43 % across 1968-2023 (AAPC -1.10 %, 95 % CI -1.19 to -1.00) but showed a recent upturn (APC +2.00 %, 95 % CI 1.53-2.57). Mortality remained higher in men than women and in Black than White individuals, increased steeply with age, and varied geographically. Bi-GRU forecasts project a modest national decline in AAMR from 1.62 to 1.47 by 2033, with persistent sex (men 1.91 vs women 1.12) and racial (Black 2.32 vs White 1.35) gaps; a slight increase is confined to the South (1.62 → 1.64), while rates in adults ≥85 years improve (10.26 → 9.70). Conclusions: While U.S. AD mortality has nearly halved over five decades, recent increases and persistent demographic and regional disparities highlight uneven progress. Forecasts to 2033 suggest modest overall declines with persistent sex and racial gaps; targeted hypertension control and regional access to high-volume aortic centers remain priorities.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.